Fleur Hudson
Impact in
Papers in
-
- HIV/AIDS drug development and treatment 5
- HIV/AIDS Research and Interventions 3
-
- Prion Diseases and Protein Misfolding 4
- Pluripotent Stem Cells Research 1
- Co-authors
- Mary A. Bedell (1 shared paper)Aparna Mahakali Zama (1 shared paper)Janet Darbyshire (4 shared papers)John Collinge (3 shared papers)Peter Rudge (4 shared papers)Angus Kennedy (2 shared papers)Sarah Walker (2 shared papers)Martin N. Rossor (1 shared paper)
- Journals
- The Lancet Neurology (4 papers)Clinical Trials (2 papers)PLoS ONE (2 papers)Emerging infectious diseases (1 paper)Therapeutic Innovation & Regulatory Science (1 paper)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Fleur Hudson
18 papers receiving 534 citations
Peers
Comparison fields: 5 of 71
- Virology 92
- Neurology 80
- Infectious Diseases 155
- Emergency Medicine 35
- Molecular Biology 248
Countries citing papers authored by Fleur Hudson
This map shows the geographic impact of Fleur Hudson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fleur Hudson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fleur Hudson more than expected).
Fields of papers citing papers by Fleur Hudson
This network shows the impact of papers produced by Fleur Hudson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fleur Hudson. The network helps show where Fleur Hudson may publish in the future.
Co-authors
The 25 scholars most cited alongside Fleur Hudson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 189 | |
| 2 | 2014 | 125 | |
| 3 | 2005 | 50 | |
| 4 | 2020 | 25 | |
| 5 | 2017 | 23 | |
| 6 | 2011 | 23 | |
| 7 | 2020 | 18 | |
| 8 | 2007 | 15 | |
| 9 | 2011 | 15 | |
| 10 | 2009 | 13 | |
| 11 | 2019 | 11 | |
| 12 | 2016 | 11 | |
| 13 | 2014 | 10 | |
| 14 | 2015 | 7 | |
| 15 | 2021 | 4 | |
| 16 | Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial. | 2014 | 1 |
| 17 | Clinical trials and methodological problems in prion diseases Reply | 2009 | 1 |
| 18 | 2009 | 1 |
About Fleur Hudson
Fleur Hudson is a scholar working on Infectious Diseases, Molecular Biology, Public Health, Environmental and Occupational Health, Virology and Neurology, having authored 18 papers that have together received 542 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (5 papers), Prion Diseases and Protein Misfolding (4 papers), HIV/AIDS Research and Interventions (3 papers), HIV Research and Treatment (2 papers), Ethics in Clinical Research (2 papers), Trypanosoma species research and implications (1 paper), Alcoholism and Thiamine Deficiency (1 paper) and Pluripotent Stem Cells Research (1 paper). The work is most often cited by research in Virology (92 citations), Neurology (80 citations), Infectious Diseases (155 citations), Emergency Medicine (35 citations) and Molecular Biology (248 citations). Fleur Hudson has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Mary A. Bedell, Aparna Mahakali Zama, Janet Darbyshire, John Collinge, Peter Rudge, Angus Kennedy, Sarah Walker, Martin N. Rossor, Suvankar Pal and Geraldine F. Keogh. Their work appears in journals such as The Lancet Neurology, Clinical Trials, PLoS ONE, Emerging infectious diseases and Therapeutic Innovation & Regulatory Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.